Sunday, March 29, 2026
spot_img
HomeNews

News

Phase 2 AXIOMATIC-SSP Study of Milvexian, Show Favorable Antithrombotic Profile

Bristol Myers Squibb in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced results from the...

New Data Show FARXIGA Significantly Lowers the Risk of Cardiovascular Death in Patients

New results from a pre-specified, patient level, pooled analysis from the Phase III DAPA-HF and DELIVER trials demonstrated mortality benefit of FARXIGA® (dapagliflozin), compared...

O-RAN ALLIANCE Announces Speakers at the Open RAN Summit at Fyuz

The Open RAN Summit  Fyuz, powered by the O-RAN ALLIANCE and Telecom Infra Project, will take place in Madrid on October 25-26, 2022, where...

Resecurity (USA) Partners With ECOMIL SAS to Accelerate Cybersecurity in Colombia

Resecurity, a U.S. cybersecurity and intelligence company, announced its partnership with ECOMIL SAS to expand Resecurity's AI-driven cybersecurity solutions and threat intelligence services to...

Lift AI Launches New Buyer Intent Integration with Drift

Lift AI, the leading buyer intent intelligence solution, announced the availability of its integration with Drift, the Conversation Cloud Company, to help marketers identify...

Hot Topics

spot_img